Renovaro Biosciences (RENB)
NASDAQ:RENB
Holding RENB?
Track your performance easily

Renovaro Biosciences (RENB) Financial Statements

134 Followers

Renovaro Biosciences Financial Overview

Renovaro Biosciences's market cap is currently ―. The company's EPS TTM is $-0.789; its P/E ratio is -0.78; Renovaro Biosciences is scheduled to report earnings on May 15, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue----$ 101.62K
Gross Profit---$ 61.22K$ 101.62K
EBIT$ -73.52M$ -17.19M$ -4.25M$ -9.00M$ -22.94M
EBITDA$ -73.40M$ -17.19M$ -4.22M$ -8.97M$ -22.91M
Net Income Common Stockholders$ -49.92M$ -17.02M$ -4.53M$ -9.18M$ -23.20M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 220.47K$ 312.70K$ 243.98K$ 523.47K$ 1.87M
Total Assets$ 163.13M$ 212.28M$ 58.02M$ 57.56M$ 58.30M
Total Debt$ 3.79M$ 8.57M$ 7.39M$ 4.60M$ 5.59M
Net Debt$ 3.57M$ 8.26M$ 7.15M$ 4.07M$ 3.72M
Total Liabilities$ 31.15M$ 43.68M$ 14.42M$ 10.82M$ 11.80M
Stockholders Equity$ 131.98M$ 168.60M$ 43.60M$ 46.75M$ 46.50M
Cash Flow-
Free Cash Flow$ -2.44M-$ -3.19M$ -2.78M$ -2.27M
Operating Cash Flow$ -2.41M$ -2.63M$ -3.15M$ -2.78M$ -2.26M
Investing Cash Flow$ -53.37K$ -91.60K$ -57.33K$ -1.06M$ -6.14K
Financing Cash Flow$ 2.47M$ 2.64M$ 2.85M$ 2.56M$ 1.25M
Currency in USD

Renovaro Biosciences Earnings and Revenue History

Renovaro Biosciences Debt to Assets

Renovaro Biosciences Cash Flow

Renovaro Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis